Chlorphenicol

Quick links to important sections

Chlorphenicol

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Chlorphenicol

Property Description
Active Ingredient Chloramphenicol
Pharmacological Class Broad-spectrum antibiotic
Type of Action Bacteriostatic (prevents bacterial growth)
Primary Forms Ophthalmic solution, oral capsules
Origin Synthetic compound

What Type of Medicine is Chlorphenicol?

Chlorphenicol is the common name for medicinal products containing the active pharmaceutical ingredient (API) Chloramphenicol, which is fundamentally classified as a broad-spectrum antibiotic and a synthetic antimicrobial agent. This compound is a synthetic substance, chemically a nitrobenzene derivative, designed to combat a wide range of susceptible bacterial infections. Chloramphenicol is characterized by its importance in treating serious infections.

Chloramphenicol functions chiefly as a bacteriostatic agent, meaning its primary mechanism is to prevent bacteria from growing and multiplying, rather than actively destroying the cells. It is an older, effective antibiotic, often reserved for specific severe infections where other agents may not be suitable.


Common Forms and Composition of Chloramphenicol

Chloramphenicol is presented in various pharmaceutical forms, including ophthalmic solutions (eye drops) and eye ointments, as well as forms for oral administration such as capsules and oral solutions. This versatility in dosage form allows the antibiotic to be delivered topically or systemically (internally). The preparation is typically a single-agent product, featuring only Chloramphenicol as the therapeutic compound. The composition requires the active ingredient to be suspended either in an aqueous vehicle for drops or combined with solid excipients for oral consumption.

Regulatory References

  1. WHO Essential Medicines List (EML)
  2. Essential Medicines List

What side effects are possible with Chlorphenicol?

Chloramphenicol is associated with serious, potentially fatal adverse reactions and is typically reserved for serious infections when alternative medicines are ineffective or contraindicated. Its safety profile is dominated by severe hematological and neurological toxicities, as documented by government regulatory agencies.


Serious and Clinically Significant Adverse Reactions

  • Fatal Blood Dyscrasias: The most critical risk is Aplastic Anemia, which is rare, unpredictable (idiosyncratic), and often fatal. It is not dose-related and may occur following brief or prolonged exposure, sometimes weeks or months after treatment has ended. Bone Marrow Suppression is a separate, dose-related effect resulting in a reversible decrease in blood cell production; this requires frequent monitoring of blood counts.

  • Gray Syndrome: This is a life-threatening toxicity unique to premature and newborn infants, who cannot adequately metabolize the medicine. Symptoms include abdominal distension, progressive pallid cyanosis (gray skin color), irregular respiration, and cardiovascular collapse.

  • Neurotoxicity: Optic neuritis (can lead to blindness) and peripheral neuropathy (tingling, numbness in hands or feet) have been reported, generally with prolonged or high-dose therapy.


Other Documented Side Effects

Commonly reported side effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Hypersensitivity reactions, including fever, rash, and angioedema, are also documented.


Safety Restrictions and Limitations

Regulatory documents highlight that the drug is contraindicated in individuals with pre-existing blood disorders or a history of hypersensitivity. Its use is strongly restricted due to the severity of the blood dyscrasias. Furthermore, the medicine has been classified in regulatory toxicological reports as a probable human carcinogen and a mutagen.

Overdose and Emergency Response

Overdose and when to seek help: Official Information

Official regulatory information for Chloramphenicol defines the primary risk not strictly as an acute overdose presentation, but as a severe, potentially fatal toxicity known as aplastic anemia and other serious blood dyscrasias (hypoplastic anemia, thrombocytopenia, and granulocytopenia).

Critical Risk Profile

  • Physiological Systems Affected: The primary system affected is the hematologic system, leading to bone marrow depression.
  • Nature of Risk: Aplastic anemia is known to occur following the administration of the drug, even at therapeutic doses, making the risk inherent to use, not just supratherapeutic exposure.

Emergency Actions and Monitoring

The risk of serious adverse effects mandates a high degree of clinical vigilance. Official safety documentation emphasizes the requirement for extensive safety monitoring throughout the course of treatment, which includes:

  • Baseline Blood Studies
  • Periodic Blood Studies: These are recommended approximately every two days during therapy to detect signs of blood disorders as early as possible.

When Immediate Medical Help is Required

Given the association with fatal outcomes and the difficulty in predicting susceptibility, any unusual bleeding, bruising, signs of infection, or unexplained fatigue during or after treatment should prompt immediate medical attention. The severity of potential blood disorders classifies this safety profile as serious, requiring continuous professional clinical oversight to mitigate risks.

Therapeutic Uses of Chlorphenicol

Chloramphenicol is commonly used to help manage bacterial diseases in two major therapeutic domains. The medication is relevant in contexts involving either localized external infections or systemic critical illnesses.

The antibiotic is applied across domains where additional symptomatic support is needed for acute, serious, and potentially life-threatening systemic bacterial diseases, such as typhoid fever and certain forms of bacterial meningitis. It is applied in clinical settings that involve acute or unstable symptom patterns, playing a role in managing the causative bacterial strain. This use contributes to easing the overall symptom load, including high fever and systemic discomfort.

For localized cases, the medication is applied in addressing superficial bacterial infections of the external eye and ear, including bacterial conjunctivitis and otitis externa. It supports the management of distressing symptoms like redness, purulent discharge, swelling, and pain.

“This medication is commonly used to help with symptom clusters that create noticeable functional strain in both acute systemic and localized inflammatory conditions.”

This application provides supportive relief when symptoms interfere with routine activities and supports general well-being in the affected area.


Quick Fact: Relief for Inflammatory Symptoms Chloramphenicol plays a role in managing symptoms related to inflammatory or irritative states of the eye (redness, discharge) and the external ear (pain, swelling).

Eligibility and Restrictions for Use

Who Can and Cannot Use Chloramphenicol?

Chloramphenicol is a powerful antibiotic whose use is strictly governed by governmental regulatory agencies due to the risk of serious side effects, particularly severe blood disorders like aplastic anemia. Official labeling defines clear populations who must not use the medicine.

Populations Who Must Not Use Chloramphenicol (Contraindications)

Contraindication Rationale (As per Official Labeling)
Prior Reaction History of hypersensitivity or toxic reaction to chloramphenicol.
Hematologic History Pre-existing bone marrow depression, aplastic anemia, or a history of myelosuppression from previous chloramphenicol exposure.
Age and Development Neonates (especially those less than 1 to 2 weeks of age) due to the risk of "Gray Syndrome."
Late Pregnancy During the late stages of pregnancy (labor or at term).
Minor Infections For the treatment of trivial infections (e.g., colds, simple sore throats) or as a prophylactic agent.

Restricted and Special Consideration Populations

Use is limited to patients with serious or life-threatening infections where less dangerous agents are ineffective or contraindicated. Special consideration and dose adjustment are often required for patients with impaired kidney or liver function.

What should I know about interactions with other medicines?

Chloramphenicol can interact with several other medications, which may alter the effectiveness or increase the side effects of either drug. It is essential to inform your healthcare provider about all medicines you are currently taking, including over-the-counter drugs, supplements, and herbal remedies.

Major Interactions

Chloramphenicol is a potent inhibitor of certain liver enzymes responsible for drug metabolism, which can significantly increase the levels of other drugs in the bloodstream, leading to potential toxicity. Key examples of major interactions include:

  • Oral Anticoagulants (e.g., Warfarin): Chloramphenicol can amplify the effect of anticoagulants, increasing the risk of bleeding. Close monitoring of International Normalized Ratio (INR) and dose adjustment is typically required.
  • Phenytoin: Chloramphenicol can significantly increase phenytoin blood levels, raising the risk of toxicity (e.g., neurological symptoms). Phenytoin levels must be closely monitored.
  • Immunosuppressants (e.g., Tacrolimus, Cyclosporine): Chloramphenicol can increase the plasma concentrations of these drugs, greatly increasing the risk of toxicity and requiring substantial dose reductions and monitoring.
  • Sulfonylureas (e.g., Chlorpropamide, Glipizide): Chloramphenicol may enhance the blood glucose-lowering effect of these diabetes medications, increasing the risk of hypoglycemia.

Decreased Chloramphenicol Efficacy

Conversely, some medications can reduce the effectiveness of chloramphenicol by increasing its metabolism in the liver. These include enzyme-inducing drugs such as Phenobarbital and Rifampicin. Combining these drugs may lead to subtherapeutic chloramphenicol levels and potential treatment failure.

Mechanism of Action

The action of Chloramphenicol is purely mechanistic, focusing on disrupting the microbial machinery necessary for replication. Its effect is classified as bacteriostatic, meaning it prevents bacterial growth without directly killing the cells.

The mechanism involves reversible binding to the 50S ribosomal subunit found within susceptible bacteria. Chloramphenicol acts as a blocker by inhibiting the peptidyl transferase enzyme, which is critical for linking amino acids to create necessary proteins. This molecular cascade immediately halts the elongation of polypeptide chains, thereby suppressing the production of structural components and enzymes required for bacterial cell growth and division.

By shutting down protein production, the drug arrests the bacteria's life cycle, arresting the proliferation of the microbial population. This physiological state of stalled replication results in suppression of the microbial population, which is functionally dependent on host immune activity for elimination. This action establishes a bacteriostatic state by constraining the rate of microbial growth.

The drug’s mechanism is functionally constrained by its potential to affect protein synthesis within mammalian mitochondrial ribosomes due to structural homology. It is also overridden in bacteria that have acquired the cat gene, which chemically inactivates Chloramphenicol, interfering with its necessary binding to the target.

Dosage and Administration Information

How to Use Chloramphenicol: Official Administration Guidelines

Chloramphenicol is officially administered either systemically through the Intravenous (IV) or Oral routes, or locally using Topical (Ophthalmic or Otic) preparations. Dosage is highly structured by body weight and context.


Administration Scope and Dosage Principles

Field Official Administration Guideline
Route of Administration Systemic: IV or Oral; Localized: Topical Ophthalmic or Otic.
Dosing Schedule Standard adult systemic dosing is 50 mg/kg/day in divided doses. In severe cases, the dose may be temporarily increased up to 100 mg/kg/day, but must be reduced as soon as possible.
Preparation Requirements The IV powder for injection must be reconstituted using an aqueous diluent (e.g., Water for Injection) prior to administration.
Age-Group Rules The total daily dose for neonates (under two weeks of age) is reduced to 25 mg/kg/day. Dose adjustments are mandatory for patients with hepatic impairment.
Special Conditions Systemic IV administration should be performed via slow injection or infusion. Therapeutic Drug Monitoring is a required procedure for systemic courses exceeding 48 hours.

Procedural Structure and Duration

The systemic total daily dose is divided into four equal parts for a precise 6-hour fixed interval frequency. Topical dosing, such as the ophthalmic ointment, is typically continued for a short course, often for at least 48 hours after the eye appears clinically normal. This procedural structure defines the standardized use by setting rigid frequency, preparation, and duration endpoints, particularly for severe systemic infections.

Recent Clinical Evidence

Chlorphenicol: Recent Clinical Evidence


Phase 3 Trials: Symptom Changes

Phase 3 studies evaluated whether there was an association with a reduction in pain. Researchers monitored changes in symptom severity over time across various trial groups. Different dose levels were investigated across the various subject groups.

  • One international, randomized trial investigated the drug in 850 participants and explored the time to onset of reported symptom changes.
  • Pharmacokinetic studies examined the effect of co-administration with meals.
  • Studies also investigated a possible association between the drug and changes in sleep quality.

Pharmacological Studies

Research investigated the drug's properties through both in-vitro and in-vivo studies.

  • Pre-clinical and laboratory studies were conducted to examine the drug’s potential activities.
  • Research was conducted to characterize the drug’s interaction with specific enzyme receptors.
  • Research evaluated the drug’s metabolism in subjects with severe liver impairment. The incidence of adverse events was documented during the clinical trials, though research has not been published or evaluated for applications outside the indications studied in the clinical trials.

Comparative Effectiveness

Studies compared this drug to older treatments currently available. The research investigated patient outcomes to describe differences between the treatment groups.

  • The combination of active ingredients was assessed against the single-ingredient formulation to characterize any additive effects.
  • Research compared the rates of adverse events reported for this drug versus other compounds.

Frequently Asked Questions (FAQ)

Common questions about Chlorphenicol (FAQ)

Q: Is Chlorphenicol the same as Chloramphenicol? What's the difference?

A: Yes, they refer to the same medication. Chlorphenicol is the common or trade name often used for medicinal products containing the active pharmaceutical ingredient, Chloramphenicol. Official regulatory documents classify it as a broad-spectrum antibiotic.

Q: Can Chlorphenicol interact with steroid medications?

A: Official product information emphasizes caution when using Chloramphenicol with other medications. The monograph for ophthalmic formulations highlights the importance of discussing all co-administered medications with a healthcare provider, especially those that may affect bone marrow function (the production of blood cells).

Q: How long after the infection clears should you continue using Chlorphenicol?

A: Regulatory guidelines typically state that topical dosing for eye infections should be continued for at least 48 hours after the eye appears clinically normal. This is a minimum duration, and it is important to complete the full treatment duration as advised by the prescriber.

Q: Can Chlorphenicol be used during pregnancy, and what does the research say?

A: According to official product information, Chloramphenicol is contraindicated (should not be used) during the late stages of pregnancy, specifically during labor or at term. This restriction is due to the potential risk of a severe condition in newborns called Gray Syndrome. Use at any other stage of pregnancy should only be considered after consulting a healthcare provider.

Q: Why is Chlorphenicol not used as much orally now compared to the past?

A: The use of oral or intravenous Chloramphenicol is generally reserved for serious or life-threatening infections when safer drugs are unavailable or ineffective. This restriction is due to the potential for serious, potentially fatal blood disorders, such as aplastic anemia, which is noted in official warnings.

Q: What happens if you stop using Chlorphenicol too early?

A: Regulatory guidance emphasizes that the medicine must be used for the full time of treatment prescribed. Stopping the antibiotic before the course is finished, even if symptoms improve, may prevent the infection from clearing completely, which could lead to symptoms returning.

Q: Why is Chlorphenicol sometimes prescribed for eye infections?

A: Chloramphenicol is officially indicated for treating superficial ocular infections, meaning infections on the surface of the eye, such as those affecting the conjunctiva or cornea. It is effective against the susceptible bacteria that commonly cause these types of infections.

Q: Why is Chlorphenicol used in some ear drop prescriptions?

A: Official product information indicates that Chloramphenicol otic (ear) drops are used to treat infections of the external ear canal. The drug is prescribed when the infection is known or suspected to be caused by bacteria that are susceptible to Chloramphenicol.

Q: Is it safe to use Chlorphenicol if I wear contact lenses?

A: Regulatory information indicates that it is generally necessary to stop wearing contact lenses during the treatment period for an infected eye. This is because the lenses can interfere with the medication and may harbor infection. Lenses should be removed during the entire course and for a period after the last dose.

Q: Are there any long-term effects of using Chlorphenicol for a few days?

A: While the drug is typically used for short courses, the regulatory documents highlight the rare but serious risk of aplastic anemia. This severe blood disorder is idiosyncratic (unpredictable), not related to the dose, and can reportedly occur following brief exposure, sometimes months after treatment has been completed.

Q: Can children use Chlorphenicol eye drops, and is the concentration different?

A: Ophthalmic formulations can generally be used in children aged 2 years and over at the same dose as adults. However, use in neonates (newborns) and children under 2 years requires special medical supervision and dose reduction due to the high risk of Gray Syndrome.

Q: What are the signs of an allergic reaction to Chlorphenicol?

A: Official sources document that signs of a serious allergic reaction may include fever, rash, angioedema (swelling beneath the skin), and anaphylaxis (a sudden, severe reaction). Local reactions in the eye may also involve irritation, swelling, or pain.

Q: Is it common to have slightly blurred vision after putting in Chlorphenicol eye drops?

A: Yes, temporary blurred vision is a commonly noted effect when the eye drops or ointment are first put into the eye. This is usually mild and clears up quickly as the medication spreads and is absorbed.

Q: Can Chlorphenicol be used for styes or just bacterial infections?

A: The drug is officially indicated for the treatment of bacterial eye infections caused by susceptible organisms. While styes are often caused by bacteria, the medication is generally used only for conditions where a bacterial origin has been confirmed or strongly suspected.

Q: What is the shelf life of Chlorphenicol eye drops once the bottle is opened?

A: Official regulatory documents define a limited in-use stability period for the topical formulations. Once the container is opened, Chloramphenicol eye drops and eye ointment must typically be discarded after 21 to 28 days, even if some medication remains.

Q: What is the ratio of active to inactive components?

A: The concentration is defined in the product monograph. For example, ear drops are commonly prepared as a 5% weight/volume (w/v) solution, and eye ointment is usually 1% weight/weight (w/w). The remaining portion of the product is composed of inactive ingredients called excipients.

Q: What happens if I accidentally put too many drops of Chlorphenicol in my eye?

A: Regulatory information states that accidental over-administration of the topical product is unlikely to cause systemic toxicity (side effects in the body) due to the low concentration. If excessive drops are used, it is generally noted that the exposed eye should be rinsed with water or an appropriate solution.

Q: Does Chlorphenicol cause sensitivity to sunlight?

A: Official patient information notes that the eye infection itself can often cause the eyes to become more sensitive to sunlight (photosensitivity). Wearing sunglasses may be a helpful way to manage this increased light sensitivity.

Q: How can I tell if my symptoms are getting better while using Chlorphenicol?

A: Official patient information advises that if there is no improvement in the condition after 2 days of treatment, or if the symptoms worsen at any time, a healthcare provider should be consulted for further evaluation.

Q: What kind of bacteria does Chlorphenicol typically kill?

A: Chloramphenicol is classified as a broad-spectrum antibiotic, meaning it is effective against a wide variety of bacteria. It is active against many types of Gram-positive and Gram-negative bacteria, including Staph. aureus, Str. pneumoniae, and Haemophilus influenzae.

Q: Is there research showing Chlorphenicol is effective against common eye pathogens?

A: Yes. Official clinical pharmacology sections in regulatory documents indicate that the drug is effective against the specific groups of organisms that commonly cause acute bacterial conjunctivitis, such as Staphylococci and Streptococci in adults and Haemophilus influenzae in children.

How should Chlorphenicol be stored and disposed of?

How to Store and Dispose of Chloramphenicol?

The official storage and disposal requirements for chloramphenicol are strictly defined by regulatory documents to maintain drug stability and ensure safety.

Storage Condition Requirement
Temperature Store unopened eye drops in a refrigerator (2 C to 8 C); do not freeze. Store eye ointment at or below 25 C or 30 C.
Protection Keep in the original container, protected from light and excessive heat, and away from moisture.

All opened or dispensed formulations have a limited in-use stability period. Eye drops and eye ointment must be discarded after 21 to 28 days following opening or dispensing, even if solution remains. The medicine must be kept out of the sight and reach of children.

Disposal must be controlled to prevent environmental contamination. Do not throw away unused or expired medicine via wastewater or household waste. Return the medicine to a pharmacy or dispose of it through an approved waste disposal program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Chlorphenicol found in:

A-Z Index: